Skyepharma Cash Flow - Annual (OTCMKTS:SKYEY)

Add to My Stocks
$6.28 $0.02 (0.32%) SKYEY stock closing price Jun 24, 2016 (Closing)

For analyzing any company like Skyepharma from an investment perspective, its important to check the cash flow statement. Financials statements like the Skyepharma income statement and Skyepharma balance sheet show that the company has profits and debt, while the cash flow statement provides details of cash flow movments. This statement can tell if a company is running out of money while still being profitable and is useful in Skyepharma stock analysis. Skyepharma had a positive net income cash flow of $40.21M for the latest 2015. This report is very useful in measuring the short term viability of a company. The cash from operating activities for Skyepharma is $ 2015, which saw a decrease from previous year.

View details of Skyepharma cash flows for latest & last 10 financial years
show more
View Previous Years
View Next Years
Fiscal year is Jan - Dec20152014201320122011201020092008
Net Income Cash Flow
Depreciation Depletion Amortization Cash-Flow4.28M5.27M6.72M4.75M4.33M5.1M5.48M10.01M
Net Increase (Decrease) in Assets Liabilities-14.37M4.94M-3.91M--2.72M14.68M-9.08M-17.8M
Cash From (used in) Discontinued Operations----9.82M----
Other Adjustments Net8.4M56.36M18.15M40.89M20.69M11.44M32.1M69.37M
Net Cash from (used by) Operating Activities
Increase (Decrease) in Prop Plant And Equipment-5.35M-1.81M-3.59M-0.79M-3.85M-6.49M-7.51M-7.79M
Acquisition Disposition of Subsidiaires---9.82M----
Increase (Decrease) in Investments--------
Other Cash Inflow (Outflow) from Investment Activities-1.37M-2.8M-1.56M-0.31M---0.15M1.48M
Net Cash from (used by) Investment Activities
Issuance (Purchase) of Equity Shares-184.58M-----34.13M
Issuance (Repayment) of Debt Securities-17.27M-184.09M-11.11M-20.13M-19.73M-15.92M-10.96M-
Increase (Decrease) in Bank & Other Borrowings--------5.56M
Payment of Dividends & Other Cash Distributions--------
Other Cash from (used by) Financing Activities-2.59M-18.78M-5.78M-15.53M-18.45M-18.09M-19.73M-32.46M
Net Cash from (used by) Financing Activities
Effect of Exchange Rate Changes on Cash1.37M-0.16M--0.15M-2.93M-1.25M8.9M
Net Change in Cash & Cash Equivalents
Cash & Equivalents at Beginning of Year49.53M26.2M25.66M24.09M46.36M41.75M55.58M58.8M
Cash & Equivalents at Year End62.83M53.39M25.81M25.99M24.38M44.68M42.27M65.85M
All figures in USD. M: Millions of USD, B: Billions of USD.
View Previous Years
View Next Years

Skyepharma stock comparison chart provides an easy way to compare the stock price with peers along with details of Skyepharma stock price history.
The statement of cash flows can be categorized into three main sections:

  • Skyepharma saw a negative change in Net Change in Cash and Cash Equivalents of $13.3M in 2015. Apart from the Skyepharma stock price, this is one of the things an investor looks for, as it shows the net change in cash on hand for a company, compared to previous period.
  • The cash generated from the core business or operations was a positive at $38.52M for Skyepharma in the latest 2015. For an internet company, this would include all those activities which are involved in eventually selling advertisement space on its website or any online service.
  • Growth companies, typically most tech companies; spend heavily on investing activities and this figure stood at $-6.72M for SKYEY stock. Sometimes a company might have a negative overall cash flow which may not be really bad if it is due to investment expenses. Hence it is important to check the cash flow from investment activities.
  • Cash flow from financing activities shows the flow of cash between Skyepharma and its owners and creditors and was $-19.87M for 2015. Financing activities allow a company to raise capital, and repay bondholders.